Capvizr
THE DEAL, AT A GLANCE

Valo Health

From the announcement
01Who is involvedBacked by VariousFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedValo Health raised $300M Series BFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersValo Health is using a $300M Series B to scale an AI multi-modal drug discovery and development platform across clinical programs and health-system data partnerships.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Valo Health · Financing Record

Explore source-linked visual explanations for Valo Health. Unsupported claims are withheld while source review continues.

Record 797 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 797 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime